Sanofi and Orano Med link for radioligand therapy development

By Yahoo! Finance | Oct 18, 2024 at 07:02 AM EST

Sanofi partners with Orano Med to advance radioligand therapies for rare cancers. The €300m investment will support the development of lead-212 based therapies, strengthening Orano Med's pipeline. The collaboration aims to innovate cancer treatment through targeted alpha-emitter therapy.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.